Post-Covid Syndrome: Pathophysiology of Systemic Disregulations
- 作者: Gomazkov O.1
-
隶属关系:
- Orekhovich Research Institute of Biomedical Chemistry
- 期: 卷 143, 编号 3 (2023)
- 页面: 229-238
- 栏目: Articles
- URL: https://journals.rcsi.science/0042-1324/article/view/138949
- DOI: https://doi.org/10.31857/S0042132423030067
- EDN: https://elibrary.ru/QQAOKZ
- ID: 138949
如何引用文章
详细
The main processes that characterize the post-COVID syndrome are analyzed as a version of the “prolonged” pathology of acute COVID-19. Considering the variety of manifestations of post-covid pathology, the main blocks of systemic, cellular and molecular dysregulations are distinguished. As the main reasons, the following are considered: the consequences of systemic and organ damage in the acute phase of COVID-19, the persistent activity of “hidden” pathogens and the altered status of the patient’s protective immune systems. Long-term pathology, as a multisystem syndrome, reflects disturbances in the main cellular and molecular regulatory systems: stochastic disorganization of immune responses, vascular endothelial dysfunction, cellular inflammation, imbalance of coagulation and antithrombosis systems, deviations in autoimmune processes, etc. These findings orient new cellular and biochemical targets for timely therapy. The varied nature of the symptoms suggests a selective use of therapeutic approaches.
作者简介
O. Gomazkov
Orekhovich Research Institute of Biomedical Chemistry
编辑信件的主要联系方式.
Email: oleg-gomazkov@yandex.ru
Russia, Moscow
参考
- Болиева Л.З., Малявин А.Г., Вялкова А.Б. Длительная персистенция вируса SARS-CoV-2 в организме как возможный механизм патогенеза долгого COVID-19 // Терапия. 2022. Т. 8 (10). С. 90–97.
- Гомазков О.А. Covid-19. Патогенез сосудистых поражений, или дьявол кроется в деталях. 2021. М.: ИКАР, 72 с.
- Гомазков О.А. Нейротропизм как механизм поражающего действия коронавируса // Успехи соврем. биол. 2022. Т. 142 (4). С. 404–416.
- Макацария А.Д., Слуханчук Е.В., Бицадзе В.О. и др. Тромботический шторм, нарушения гемостаза и тромбовоспаление в условиях COVID-19 // Акушерство, гинекол. репрод. 2021. 15 (5). С. 499–514. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.247
- Методические рекомендации “Особенности течения Long-COVID-19 инфекции. Терапевтические и реабилитационные мероприятия” / Ред. А.И. Мартынов (утверждены на ХVI Национальном Конгрессе терапевтов 18.11.2021). 217 с.
- Ackermann M, Verleden S.E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 // N. Engl. J. Med. 2020. V. 383 (2). P. 120–128. https://doi.org/10.1056/NEJMoa2015432
- Ahamed J., Laurence J.J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches // Clin. Invest. 2022. V. 132 (15). P. e161167.
- Ambrosino P., Bachetti T., D’Anna S.E. et al. Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension // J. Cardiovasc. Dev. Dis. 2022. V. 9 (5). P. 136. https://doi.org/10.3390/jcdd9050136
- Amenta E.M., Spallone A., Rodriguez-Barradas M.C. et al. Post-acute COVID-19: an overview and approach to classification // Open Forum Infect. Dis. 2020. V. 7 (12). P. ofaa509. https://doi.org/10.1093/ ofid/ofaa509
- Ayoubkhani D., Khunti K., Nafilyan V. et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study // BMJ. 2021. V. 372. P. n693. https://doi.org/10.1136/bmj.n693
- Babkina A.S., Ostrova I.V., Yadgarov M.Y. et al. The role of von Willebrand factor in the pathogenesis of pulmonary vascular thrombosis in COVID-19 // Viruses. 2022. V. 14 (2). P. 211. https://doi.org/10.3390/v14020211
- Bogdanov V.Y., Khirmanov V.N. SARS-CoV-2, platelets, and endothelium: coexistence in space and time, or a pernicious ménage à trois? // Vasc. Biol. 2022. V. 4 (1). P. R35–R43. https://doi.org/10.1530/VB-22-0004
- Castanares-Zapatero D., Chalon P., Kohn L. et al. Pathophysiology and mechanism of long COVID: a comprehensive review // Ann. Med. 2022. V. 54 (1). P. 1473–1487. https://doi.org/10.1080/07853890.2022.2076901
- Chang H.W., Leu S., Sunet C.K. et al. Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies // Transl. Res. 2010. V. 156 (4). P. 251–263. https://doi.org/10.1016/j.trsl.2010.07.010
- Che Mohd Nassir C.M.N., Hashim S., Wong K.K. et al. COVID-19 infection and circulating microparticles – reviewing evidence as microthrombogenic risk factor for cerebral small vessel disease // Mol. Neurobiol. 2021. V. 58 (8). P. 4188–4215. https://doi.org/10.1007/s12035-021-02457-z
- Chen Y., Xu Z., Wang P. et al. New-onset autoimmune phenomena post-COVID-19 vaccination // Immunology. 2022. V. 165 (4). P. 386–401. https://doi.org/10.1111/imm.13443
- Chioh F.W., Fong S.W., Young B.E. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation // Elife. 2021. V. 10. P. e64909. https://doi.org/10.7554/eLife.64909
- Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection:illness beyond acute infection and public health implications // JAMA. 2020. V. 324 (22). P. 2251–2252. https://doi.org/10.1001/jama.2020.22717
- DiSabato D.J., Quan N., Godbout J.P. Neuroinflammation: the devil is in the details // J. Neurochem. 2016. V. 139. Sup. 2. P. 136–153. https://doi.org/10.1111/jnc.13607
- Doeblin P., Steinbeis F., Scannell C.M. et al. Brief research report: quantitative analysis of potential coronary microvascular disease in suspected long-COVID syndrome // Front. Cardiovasc. Med. 2022. V. 9. P. 877416. https://doi.org/10.3389/fcvm.2022.877416
- Dorward D.A., Russell C.D, Um I.H. et al. Tissue-specific immunopathology in fatal COVID-19 // Am. J. Respir. Crit. Care Med. 2021. V. 203 (2). P. 192–201. https://doi.org/10.1164/rccm.202008-3265OC
- Dotan A., Muller S., Kanduc D. et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity // Autoimmun. Rev. 2021. V. 20 (4). P. 102792. https://doi.org/10.1016/j.autrev.2021.102792
- Fogarty H., Ward S.E., Townsend L. et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in longCOVID syndrome is related to immune dysfunction // J. Thromb. Haemost. 2022. V. 20 (10). P. 2429–2438. https://doi.org/10.1111/jth.15830
- Fujinami R.S., von Herrath M.G., Christen U., Whittonl J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease // Clin. Microbiol. Rev. 2006. V. 19. P. 80–94. https://doi.org/10.1128/CMR.19.1.80-94.2006
- Fujisawa T., Tura-Ceide O., Hunter A. et al. Endothelial progenitor cells do not originate from the bone marrow // Circulation. 2019. V. 140. P. 1524–1526.https://doi.org/10.1161/CIRCULATIONAHA.119.042351
- García-Abellán J., Fernández M., Padilla S. et al. Immunologic phenotype of patients with long-COVID syndrome of 1-year duration // Front. Immunol. 2022. V. 13. P. 920627. https://doi.org/10.3389/fimmu.2022.920627
- Gomazkov O.A. Damage of the vascular endothelium as a leading mechanism of COVID-19 systemic pathology // Biol. Bull. Rev. 2021. V. 11 (6). P. 559–566. https://doi.org/10.1134/S2079086421060049
- Gupta A., Madhavan M.V., Sehgal K. et al. Extrapulmonary manifestations of COVID-19 // Nat. Med. 2020. V. 26. P. 1017–1032. https://doi.org/10.1038/s41591-020-0968-3
- Haffke M., Freitag H., Rudolf G. et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) // J. Transl. Med. 2022. V. 20. P. 138. https://doi.org/10.1186/s12967-022-03346-2
- Iba T., Levy J.H., Levi M., Thachil J. Coagulopathy in COVID-19 // J. Thromb. Haemost. 2020. V. 18 (9). P. 2103–2109. https://doi.org/10.1111/jth.14975
- Jacobs J.J.L. Persistent SARS-2 infections contribute to long COVID-19 // Med. Hypotheses. 2021. V. 149. https://doi.org/10.1016/j.mehy.2021.110538
- Jud P., Gressenberger P., Muster V. et al. Evaluation of endothelial dysfunction and inflammatory vasculopathy after SARS-CoV-2 infection – a cross-sectional study // Front. Cardiovasc. Med. 2021. V. 8. P. 750887. https://doi.org/10.3389/fcvm.2021.750887
- Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications // Biochem. J. 2022. V. 479 (4). P. 537–559. https://doi.org/10.1042/BCJ20220016
- Kemp S.A., Collier D.A., Datir R.P. et al. SARS-CoV-2 evolution during treatment of chronic infection // Nature. 2021. V. 592 (7853). P. 277–282. https://doi.org/10.1038/s41586-021-03291-y
- Khoshkam Z., Aftabi Y., Stenvinkel P. et al. Recovery scenario and immunity in COVID-19 disease: a new strategy to predict the potential of reinfection // J. Adv. Res. 2021. V. 31. P. 49–60. https://doi.org/10.1016/j.jare.2020.12.013
- Kostov K. The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling,and blood pressure regulation // Life (Basel). 2021. V. 11 (9). P. 986. https://doi.org/10.3390/ life11090986
- Koutroumpi M., Dimopoulos S., Psarra K. et al. Circulating endothelial and progenitor cells: evidence from acute and long-term exercise effects // World J. Cardiol. 2012. V. 4 (12). P. 312–326. https://doi.org/10.4330/wjc.v4.i12.312
- Kruger A., Vlok M., Turner S. et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system // Cardiovasc. Diabetol. 2022. V. 21 (1). P. 190. https://doi.org/10.1186/s12933-022-01623-4
- Ladikou E.E., Sivaloganathan H., Milne K.M. et al. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? // Clin. Med. 2020. V. 20 (5). P. e178–e182. https://doi.org/10.7861/clinmed.2020-0346
- Liew A., Barry F., O’Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations // Bioessays. 2006. V. 28 (3). P. 261–270. https://doi.org/10.1002/bies.20372
- Liotti F.M., Menchinelli G., Marchetti S. et al. Assessment of SARS-CoV-2 RNA test results among patients who recovered from COVID-19 with prior negative results // JAMA Int. Med. 2020. V. 181. P. 702–704. https://doi.org/10.1001/jamainternmed.2020.7570
- Lowenstein C.J., Solomon S.D. Severe COVID-19 is a microvascular disease // Circulation. 2020. V. 142 (17). P. 1609–1611. https://doi.org/10.1161/CIRCULATIONAHA.120.050354
- Maltezou H.C., Pavli A., Tsakris A. Post-COVID syndrome: an insight on its pathogenesis // Vaccines (Basel). 2021. V. 9 (5). P. 497. https://doi.org/10.3390/vaccines9050497
- Mantovani A., Morrone M.C., Patronoet P. et al. Long Covid: where we stand and challenges ahead. Covid-19 Commission of the Accademia Nazionale dei Lincei // Cell Death Differ. 2022. V. 29 (10). P. 1891–1900. https://doi.org/10.1038/s41418-022-01052-6
- Mehandru S., Merad M. Pathological sequelae of long-haul Covid // Nat. Immunol. 2022. V. 23. P. 194–202. https://doi.org/10.1038/s41590-021-01104-y
- Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation // Physiol. Rep. 2021. V. 9 (3). P. e14726. https://doi.org/10.14814/phy2.14726
- Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms // Front Microbiol. 2021. V. 12. P. 698169.
- Prasannan N., Heightman M., Hillman T. et al. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis // Blood Adv. 2022. V. 6 (13). P. 4041–4048. https://doi.org/10.1182/bloodadvances.2021006944
- Priya S.P., Sunil P.V., Varmaet S. et al. Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview // Virusdisease. 2022. V. 33 (4). P. 429–444. https://doi.org/10.1007/s13337-022-00793-9
- Puelles V.G., Lütgehetmann M., Lindenmeyer M.T. et al. Multiorgan and renal tropism of SARS-CoV-2 // New Engl. J. Med. 2020. V. 383. P. 590–592. https://doi.org/10.1056/NEJMc2011400
- Raman B., Cassar M.P., Tunnicliffe E.M. et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge // EClinicalMedicine. 2021. V. 31. Art.100683. https://doi.org/10.1016/j.eclinm.2020.100683
- Ryan F.J., Hope C.M., Masavuli M.G. et al. Long-term perturbation of the peripheral immune system after SARS-CoV-2 infection // BMC Med. 2022. V. 20 (1). P. 26. https://doi.org/10.1186/s12916-021-02228-6
- Sarkesh A., Sorkhabi A.D., Sheykhsaran E. et al. Extrapulmonary clinical manifestations in COVID-19 patients // Am. J. Trop. Med. Hyg. 2020. V. 103 (5). P. 1783–1796. https://doi.org/10.4269/ajtmh.20-0986
- Scherbakov N., Szklarski M., Hartwiget J. et al. Peripheral endothelial dysfunction in myalgic encephalomyelitis /chronic fatigue syndrome // ESC Heart Fail. 2020. V. 7 (3). P. 1064–1071. https://doi.org/10.1002/ehf2.12633
- Sen S., McDonald S.P., Coates P.T.H., Bonder C.S. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease // Clin. Sci. (Lond.). 2011. V. 120. P. 263–283. https://doi.org/10.1042/CS20100429
- Siddiqi H.K., Libby P., Ridker P.M. COVID-19 – a vascular disease // Trends Cardiovasc. Med. 2021. V. 31 (1). P. 1–5. https://doi.org/10.1016/j.tcm.2020.10.005
- Stein S.R., Ramelli S.C., Grazioliet A. et al. SARS-CoV-2 infection and persistence throughout the human body and brain // Nature. 2022. V. 612 (7941). P. 758–763. https://doi.org/10.1038/s41586-022-05542-y
- Sun J., Xiao J., Sunet R. et al. Prolonged persistence of SARS-CoV-2 RNA in body fluids // Emerg. Infect. Dis. 2020. V. 26. P. 1834–1838. https://doi.org/10.3201/eid2608.201097
- Tehrani H.A., Darnahal M., Nadji S.A., Haghighil S. COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review // New Microb. New Infect. 2021. V. 39. P. 100830. https://doi.org/10.1016/j.nmni.2020.100830
- Welte T. SARS-CoV-2-triggered immune reaction: for COVID-19, nothing iIs as old as yesterday’s knowledge // Am. J. Respir. Crit. Care Med. 2021. V. 203 (2). P. 156. https://doi.org/10.1164/rccm.202011-4194ED
- Wirth K.J., Scheibenbogen C., Friedemann P. An attempt to explain the neurological symptoms of myalgic encephalomyelitis/chronic fatigue syndrome // J. Transl. Med. 2021. V. 19 (1). P. 471. https://doi.org/10.1186/s12967-021-03143-3
- Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies // Rev. Med. Virol. 2021. V. 32 (4). P. e2315. https://doi.org/10.1002/rmv.2315
- Zhang J., Tecson K.M., McCullough P.A. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy // Rev. Cardiovasc. Med. 2020. V. 21 (3). P. 315–319. https://doi.org/10.31083/j.rcm.2020.03.12
![](/img/style/loading.gif)